erb-257
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2008 (NCT00722501)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Estrogen receptor betaAGONIST
ESR2 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- erb-257
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00722202 | Phase 1 | Oct 1, 2008 | Pfizer, Wyeth |
| NCT00722501 | Phase 1 | Aug 1, 2008 | Pfizer, Wyeth |
Showing 2 of 2 trials
Page 1 / 1